If you think the work of the advisory committee is to be hand holders and communicating to shareholders I think you have a misunderstanding of what is going to happen here.
Imo, this committee is looking at the big picture and more than likely going to be a sponsor of a dynamic move. Like a massive Dutch Tender, an LBO or even an out right sale of the company.
The main job that they will be facing is what would make the shorts go away and the likely answer is that there is nothing.
Consider this, they had them on the run when the stock went from $18 to $74 and probably caused them a lot of pain but they didn't get rid of them and probably won't by buying in stock. The shorts will be here years from now unless they are able to break their backs.
That is why I think were in for more than a average idea and more than likely has the top people in the company looking over the idea of an lbo. Obviously the cash flow would support it, further it would allow the company to come back public in 3-5 years when the development of our drugs are further along and probably make top management a major killing at the time.
You also have a chance that by making of these comments public that this company has been receiving inquiries from large drug companies about a possible buyout. So I wouldn't rule this out either. Lets face it a Pfizer type would be awfully tough to start a short attack over this one product as it wouldn't amount to enough of their sales if the story was able to stick.
The dutch tender idea would have to be for a large portion of the float or I don't think it works very well. Meaning for maybe as much as 30-40% of the stock. When you get to a number like this your starting to talk to bankers that might just have you thinking about this lbo idea as being more appealing.
south81 I'm more inclined to believe that they would rather have this continue south but are concerned that they will run out of shares available to use for shorting, further at some point if the short numbers get too high they have to be concerned with getting called on the borrowed shares.
Not a good proposition in the long run, imo.
So am I.
By now you can add on another 2 million above this. The shorts could be approaching the area where holding their borrowed shares gets tougher.
Little guy shorts will be the first to have trouble, imo.
The purpose of all these articles is to collapse the stock.
While I hope they are trapped and not going to recover, I won't leap to that conclusion just yet. Not sure what else they have up their sleeve but do think this isn't the end of their nonsense.
I don't think of these as nice people.
It would make sense that with each day of shorting that there would be less shares available.... I would think that institutions would be sharp enough to not be loaning shares to these guys when its quite obvious that the shares will be used against them.
I'm thinking that the shorting in the month of December is going to show some mighty large number increases for both reporting periods.
Well this would be high on my list too and the reason being that a Dutch Tender at say $65-68 flies and with the expected progress in sales your talking about a move that really does enhance shareholder value for the remaining holders.
Further this type move probably would do real damage to the shorts in the long run as in order to borrow that kind of money they would have to put the lenders at ease about all this silly talk that the shorts are doing.
Hope this is what this committee comes up with. Though I do think there is a chance that as a result of those public comments that a couple big pharma's inquire with interest in taking out the company.
I think that I would prefer the first move rather than a buyout but would be fine with either.
I thought Left sold his shares earlier this year.
Heck I was wondering if he might short this company or maybe did the other day when all that volume hit the stock..
When they said seeking alternatives you have to consider that quite possibly that would include selling the company.
The people trying to bring this company down would have a hard time using these tactics on a Pfizer or a Merck or anyone else where the overall revenue produced by this product would just be a small portion of a BP's sales.
if the pressure remains of a nature where the survival of QCOR is at stake the board will have little alternative than to make a bold move. I suspect that if they go this route that we will hear an announcement stating such.
Not sure just what else the board can do to protect the brand but you can bet that when they get together for their quarterly meetings or special meetings that this is a topic that has gotten their attention and one that they are now taking seriously.
To me the question is what is $1 billion in revenue and growing at a phenomenal rate with good profits attached worth to a Big Pharma and will 3 or 4 of them bid for it.
I wish I knew.
Not sure how this goes but one thing is certain in that it causes the shorts to have to use shorting shares faster than they may want to do. There is a limit on how many they can borrow folks.
Interestingly buyers seem to be taking size offers more quickly now.
The guy seems to be a follower instead of a leader.
Wonder how happy he is with that short of HLF that him and Ackman did back when it was way lower.
You would think he would stop being such a follower after that one..
I agree, maybe people that own the stock are now smarter toward these attacks.
I know that I am.
Not only that but when analysts from Janney and Oppenheimer (and soon others) are giving words of comfort it shows that they think this is all baloney.
Didn't that filing show that he sold them in some kind of transaction? I believe it did so who knows maybe he did do a massive short yesterday.
Obviously someone bought and someone sold. I do think that a lot of those shares were shorts as the volume was way too great when compared to normal.
There is only one way to find out.
I think Mikey got in trouble with his last article because he named names and tied them together in such a fashion that it really upset some people.
If someone writes an article that stays with the issues of this company and the realities of making that new drug I think it flies even if it kinda crosses the line a little a few times.
As I said there is only one way to find out.
I never expected them to lie back and not hit the stock. but after how this day is working out you have to believe that they now understand that taking QCOR down won't be as easy as they thought as QCOR has friends of their own in the investment community.
If it turns out that it is does it really matter in the long term scheme of things?
I think the company will know how to handle this matter under that condition.
I'm guessing were near 20 million shares unless all this is designed to cover shares and is deception at its very best.